Abstract

BackgroundArsenic (As) exposure is a significant worldwide environmental health concern. Low dose, chronic arsenic exposure has been associated with a higher than normal risk of skin, lung, and bladder cancer, as well as cardiovascular disease and diabetes. While arsenic-induced biological changes play a role in disease pathology, little is known about the dynamic cellular changes resulting from arsenic exposure and withdrawal.ResultsIn these studies, we sought to understand the molecular mechanisms behind the biological changes induced by arsenic exposure. A comprehensive global approach was employed to determine genome-wide changes to chromatin structure, transcriptome patterns and splicing patterns in response to chronic low dose arsenic and its subsequent withdrawal. Our results show that cells exposed to chronic low doses of sodium arsenite have distinct temporal and coordinated chromatin, gene expression, and miRNA changes consistent with differentiation and activation of multiple biochemical pathways. Most of these temporal patterns in gene expression are reversed when arsenic is withdrawn. However, some gene expression patterns remained altered, plausibly as a result of an adaptive response by cells. Additionally, the correlation of changes to gene expression and chromatin structure solidify the role of chromatin structure in gene regulatory changes due to arsenite exposure. Lastly, we show that arsenite exposure influences gene regulation both at the initiation of transcription as well as at the level of splicing.ConclusionsOur results show that adaptation of cells to iAs-mediated EMT is coupled to changes in chromatin structure effecting differential transcriptional and splicing patterns of genes. These studies provide new insights into the mechanism of iAs-mediated pathology, which includes epigenetic chromatin changes coupled with changes to the transcriptome and splicing patterns of key genes.Electronic supplementary materialThe online version of this article (doi:10.1186/s12864-015-1295-9) contains supplementary material, which is available to authorized users.

Highlights

  • Arsenic (As) exposure is a significant worldwide environmental health concern

  • Our findings demonstrate that the adaptational changes due to inorganic arsenic (iAs) exposure involve changes to chromatin structure, gene expression as well as the production of specific gene isoforms

  • Exposure to low doses of sodium arsenite suppresses cell growth and modulates cell morphology To understand the effect of long-term iAs exposure on cells resulting in epithelial-to-mesenchymal transition (EMT), we carried out studies in normal lung epithelial BEAS-2B cells, bearing in mind that the lung is a major cellular target of iAs carcinogenesis [4,14,15,16,17,18]

Read more

Summary

Introduction

Arsenic (As) exposure is a significant worldwide environmental health concern. Low dose, chronic arsenic exposure has been associated with a higher than normal risk of skin, lung, and bladder cancer, as well as cardiovascular disease and diabetes. In some regions of the world, especially coal mining regions, inorganic arsenic (iAs) levels in drinking water can exceed those recommended by the World Health Organization [1,2]. Arsenic is found in several different chemical forms and oxidation states and its metabolism has an important role in its toxicity. The metabolism of arsenic is catalyzed by Arsenic (+3 oxidation state) methyltransferase 1 (AS3MT 1) which catalyzes conversion of iAs to methylated arsenicals. This process involves a sequential reduction of iAs5+ to iAs3+ followed by oxidative methylation to monomethylarsonic acid (MMA5+) and dimethylarsinic acid (DMA5+).

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call